Volume 13, Number 10—October 2007
Research
Personal Protective Equipment and Antiviral Drug Use during Hospitalization for Suspected Avian or Pandemic Influenza1
Table 2
Characteristic | Hospital |
||||||||
---|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | G | H | I | |
State | VIC | VIC | VIC | VIC | VIC | TAS | VIC | VIC | NSW |
Urban/regional | Urban | Urban | Urban | Urban | Regional | Urban | Urban | Urban | Urban |
Inpatient beds, no. | 840 | 320 | 750 | 450 | 400 | 490 | 400 | 400 | 880 |
Annual admissions | 67,700 | 40,000 | 79,500 | 47,200 | 61,200 | 52,300 | 45,300 | 93,100 | 71,600 |
Total simulation time, h | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 2.5 | 2.5 |
Triage time, h | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 |
ED time, h† | 2 | 2.9 | 3 | 1.9 | 2.2 | 1.5 | 2.4 | 2.3‡ | 2.4‡ |
Ward time, h | 3.7 | 2.8 | 3 | 3.9 | 3.7 | 4.4 | 3.5 | – | – |
*VIC, Victoria; TAS, Tasmania; NSW, New South Wales; ED, emergency department.
†Includes time spent in ED radiology unit.
‡Simulation of avian or pandemic influenza ended prematurely because beds were needed.
1This research was presented in part at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, September 17-20, 2007.
Page created: July 02, 2010
Page updated: July 02, 2010
Page reviewed: July 02, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.